Anqi Ma
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
Papers in
-
- Epigenetics and DNA Methylation 19
- Histone Deacetylase Inhibitors Research 11
- Protein Degradation and Inhibitors 8
- Cancer-related gene regulation 7
- Ubiquitin and proteasome pathways 4
- RNA modifications and cancer 4
- Genomics and Chromatin Dynamics 3
-
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Jian Jin (29 shared papers)Masoud Vedadi (5 shared papers)Fengling Li (5 shared papers)Peter J. Brown (6 shared papers)Kwang‐Su Park (3 shared papers)Ling Cai (4 shared papers)Gang Greg Wang (4 shared papers)C.H. Arrowsmith (6 shared papers)
- Journals
- Blood (5 papers)Journal of Medicinal Chemistry (4 papers)Oncotarget (3 papers)Nature Communications (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesCanadaSweden
In The Last Decade
Anqi Ma
31 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 69
- Hematology 196
- Molecular Biology 1.1k
- Cancer Research 157
- Oncology 150
- Immunology 61
Countries citing papers authored by Anqi Ma
This map shows the geographic impact of Anqi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Ma more than expected).
Fields of papers citing papers by Anqi Ma
This network shows the impact of papers produced by Anqi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Ma. The network helps show where Anqi Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Anqi Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 177 | |
| 2 | 2019 | 174 | |
| 3 | 2022 | 126 | |
| 4 | 2014 | 75 | |
| 5 | 2017 | 75 | |
| 6 | 2017 | 63 | |
| 7 | 2016 | 60 | |
| 8 | 2019 | 53 | |
| 9 | 2013 | 48 | |
| 10 | 2016 | 48 | |
| 11 | 2016 | 46 | |
| 12 | 2014 | 42 | |
| 13 | 2019 | 39 | |
| 14 | 2017 | 38 | |
| 15 | 2022 | 35 | |
| 16 | 2019 | 30 | |
| 17 | 2016 | 29 | |
| 18 | 2017 | 29 | |
| 19 | 2015 | 26 | |
| 20 | 2014 | 25 |
About Anqi Ma
Anqi Ma is a scholar working on Molecular Biology, Hematology, Cancer Research, Pathology and Forensic Medicine and Physiology, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (19 papers), Histone Deacetylase Inhibitors Research (11 papers), Protein Degradation and Inhibitors (8 papers), Cancer-related gene regulation (7 papers), Multiple Myeloma Research and Treatments (5 papers), Ubiquitin and proteasome pathways (4 papers), RNA modifications and cancer (4 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Hematology (196 citations), Molecular Biology (1.1k citations), Cancer Research (157 citations), Oncology (150 citations) and Immunology (61 citations). Anqi Ma has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Jian Jin, Masoud Vedadi, Fengling Li, Peter J. Brown, Kwang‐Su Park, Ling Cai, Gang Greg Wang, C.H. Arrowsmith, David F. Allison and Stephen V. Frye. Their work appears in journals such as Blood, Journal of Medicinal Chemistry, Oncotarget, Nature Communications and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.